BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23734690)

  • 1. Soluble form of urokinase-type plasminogen activator receptor as a diagnostic and prognostic marker in hematological patients with neutropenic fever.
    Vänskä M; Purhonen AK; Koivula I; Jantunen E; Hämäläinen S; Pulkki K; Juutilainen A
    Leuk Lymphoma; 2014 Mar; 55(3):718-21. PubMed ID: 23734690
    [No Abstract]   [Full Text] [Related]  

  • 2. The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.
    Kaya S; Köksal I; Menteşe A; Sönmez M; Sümer A; Yıldırım SS; Yılmaz G
    Int J Infect Dis; 2013 Nov; 17(11):e1056-9. PubMed ID: 23742830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic value of soluble urokinase plasminogen activator receptor compared with C-reactive protein and procalcitonin in children with febrile neutropenia.
    Sirinoglu M; Soysal A; Karaaslan A; Kepenekli Kadayifci E; Cinel I; Koç A; Tokuç G; Yaman A; Haklar G; Şirikçi Ö; Turan S; Altınkanat Gelmez G; Söyletir G; Bakır M
    Pediatr Hematol Oncol; 2016 Apr; 33(3):200-8. PubMed ID: 27057782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Febrile neutropenia: significance of elaborated screening for respiratory viruses, and the comparison of different sampling methods, in neutropenic patients with hematological malignancies.
    Jansen RR; Biemond BJ; Schinkel J; Koekkoek SM; Molenkamp R; de Jong MD; Visser CE
    Virol J; 2013 Jun; 10():212. PubMed ID: 23805898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients.
    Koizumi Y; Shimizu K; Shigeta M; Okuno T; Minamiguchi H; Kito K; Hodohara K; Yamagishi Y; Andoh A; Fujiyama Y; Mikamo H
    BMC Infect Dis; 2017 Jan; 17(1):27. PubMed ID: 28056845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies.
    Baraka A; Zakaria M
    Int J Hematol; 2018 Aug; 108(2):184-191. PubMed ID: 29616457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's new in diagnosis and antimicrobial therapy of febrile neutropenic patients with lung infiltrates?
    Rieger C; Barlow S; Maschmeyer G
    Intensive Care Med; 2014 Oct; 40(10):1549-52. PubMed ID: 24972884
    [No Abstract]   [Full Text] [Related]  

  • 8. Febrile neutropenia in hematologic malignancies.
    Keng MK; Sekeres MA
    Curr Hematol Malig Rep; 2013 Dec; 8(4):370-8. PubMed ID: 23990311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men.
    Haugaard SB; Andersen O; Hansen TW; Eugen-Olsen J; Linneberg A; Madsbad S; Olsen MH; Jørgensen T; Borch-Johnsen K; Jeppesen J
    Diabet Med; 2012 Apr; 29(4):479-87. PubMed ID: 22050462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker candidates for the detection of an infectious etiology of febrile neutropenia.
    Richter ME; Neugebauer S; Engelmann F; Hagel S; Ludewig K; La Rosée P; Sayer HG; Hochhaus A; von Lilienfeld-Toal M; Bretschneider T; Pausch C; Engel C; Brunkhorst FM; Kiehntopf M
    Infection; 2016 Apr; 44(2):175-86. PubMed ID: 26275448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplex PCR assay underreports true bloodstream infections with coagulase-negative staphylococci in hematological patients with febrile neutropenia.
    Reers Y; Idelevich EA; Pätkau H; Sauerland MC; Tafelski S; Nachtigall I; Berdel WE; Peters G; Silling G; Becker K;
    Diagn Microbiol Infect Dis; 2016 Aug; 85(4):413-5. PubMed ID: 27220608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in Crimean-Congo hemorrhagic fever.
    Yilmaz G; Mentese A; Kaya S; Uzun A; Karahan SC; Koksal I
    J Clin Virol; 2011 Mar; 50(3):209-11. PubMed ID: 21167774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble triggering receptor expressed on myeloid cells-1 as an infection marker for patients with neutropenic fever.
    Lin CH; Yao M; Hsu SC; Ho CC; Lin MT; Lin CA; Hu FC; Yu CJ; Tien HF
    Crit Care Med; 2011 May; 39(5):993-9. PubMed ID: 21283000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From lactate to soluble urokinase plasminogen activator receptor: The journey for ideal cardiac biomarker: Are we there in 2016?
    Kapoor PM
    Ann Card Anaesth; 2016; 19(2):211-3. PubMed ID: 27052058
    [No Abstract]   [Full Text] [Related]  

  • 15. Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening.
    Kjellman A; Akre O; Gustafsson O; Høyer-Hansen G; Lilja H; Norming U; Piironen T; Törnblom M
    J Intern Med; 2011 Mar; 269(3):299-305. PubMed ID: 21138491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Changes of Mannose-Binding Lectin, H-Ficolin, and Procalcitonin in Patients with Febrile Neutropenia: A Prospective Observational Study.
    Işlak Mutcalı S; Saltoğlu N; Balkan İİ; Özaras R; Yemişen M; Tabak F; Mert A; Öztürk R; Öngören Ş; Başlar Z; Aydın Y; Ferhanoğlu B; Soysal T
    Turk J Haematol; 2016 Dec; 33(4):304-310. PubMed ID: 26377840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SuPAR, an emerging biomarker in kidney and inflammatory diseases.
    Hamie L; Daoud G; Nemer G; Nammour T; El Chediak A; Uthman IW; Kibbi AG; Eid A; Kurban M
    Postgrad Med J; 2018 Sep; 94(1115):517-524. PubMed ID: 30177549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
    Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
    Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial.
    Oyake T; Kowata S; Murai K; Ito S; Akagi T; Kubo K; Sawada K; Ishida Y
    Eur J Haematol; 2016 Jun; 96(6):602-9. PubMed ID: 26216048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia.
    Erkut N; Menteşe A; Özbaş HM; Ermantaş N; Sümer A; Örem A; Sönmez M
    Turk J Haematol; 2016 Jun; 33(2):135-40. PubMed ID: 26376588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.